Reducing medications safely to meet life’s changes
What medications were good then might not be the best choice now. Deprescribing is the planned process of reducing or stopping medications that may no longer be of benefit or may be causing harm. The goal is to reduce medication burden or harm while improving quality of life.
Be part of the change for a better quality of life
Patients
Learn about deprescribing and check out resources to help you discuss deprescribing with your health care provider.
Health Care Providers
Get comfortable deprescribing with tools and resources, case reports and testimonials, and relevant publications.
Researchers
Find out about ongoing research at Bruyère Research Institute and the University of Montreal and join the conversation to share your own research.
As the population ages, older Canadians are living with multiple chronic conditions. In 2016, 35% of community-dwelling seniors had chronic use of 5 or more different drug classes.
Inappropriate prescriptions are known to pose health risks for older adults, leading to unnecessary hospitalisations and undue cost.
“It is an art of no little importance to administer medicines properly; but it is an art of much greater and more difficult acquisition to know when to suspend or altogether omit them.”
What’s happening?
Literature Roundup #2 – Do health professional students know about deprescribing?
Welcome to our next literature roundup. We apologize that things have been a bit slow around here, but they will be picking them up again starting…now. Do health professional students know about deprescribing? Here is a simple and very important question: do pharmacy...
Starting to stop: The birth of a deprescribing research portfolio at Hospital Pharmacy Funen, Denmark
By Carina Lundby, Wade Thompson and Anton Pottegård In the Research Unit at Hospital Pharmacy Funen, Odense University Hospital, Denmark, deprescribing constitutes our main research area. Although we are a small group of researchers, we have worked with deprescribing...
Guest Blog Post #2: 2019 Australian Deprescribing Network (ADeN) Annual Meeting
Hi everyone, welcome to our second guest blog post. Today we will have Drs. Emily Reeve and Danijela Gnjidic telling us about the annual meeting of the Australian Deprescribing Network. 2019 Australian Deprescribing Network (ADeN) Annual Meeting By: Dr. Emily Reeve...
Keep up with the latest
Recent study shows that poor communication and infrequent #medication reviews are among barriers to effective medic… twitter.com/i/web/status/1…
Happy #CanadaDay from the Bruyère #Deprescribing Research Team! This #CanadaDay, we’re celebrating healthcare worke… twitter.com/i/web/status/1…
Recent pilot study determines that collaborative interventions between pharmacist and primary #healthcare physician… twitter.com/i/web/status/1…
Optimizing medications for patients with cancer and multimorbidity: The case for #deprescribing @OptimisingRxUse ow.ly/IcfC50AgVcX
New guest blog post featuring @NJAilabouni - To deprescribe or not to deprescribe? Considerations in older adults w… twitter.com/i/web/status/1…
Large randomized controlled trial on the use of an electronic decision support tool to reduce #polypharmacy in olde… twitter.com/i/web/status/1…
Would you like to get more involved?
Are you a patient, a caregiver or a researcher? You can participate in the deprescribing conversation. Find out more.
Would you like more information?
We are here to help you. If you wish to obtain more information concerning elements found on our site, please contact us.